BG
EBS icon

BlackRock Group’s Emergent Biosolutions EBS Stock Holding History

BlackRock Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.8M Buy
85,199
+17,107
+25% +$513K ﹤0.01% 1530
2016
Q3 		$2.15M Buy
68,092
+3,824
+6% +$111K ﹤0.01% 1574
2016
Q2 		$1.81M Buy
64,268
+8,757
+16% +$343K ﹤0.01% 1619
2016
Q1 		$2.02M Buy
55,511
+9,213
+20% +$325K ﹤0.01% 1538
2015
Q4 		$1.85M Buy
46,298
+13,464
+41% +$469K ﹤0.01% 1526
2015
Q3 		$936K Sell
32,834
-4,355
-12% -$144K ﹤0.01% 1922
2015
Q2 		$1.23M Sell
37,189
-5,556
-13% -$172K ﹤0.01% 1839
2015
Q1 		$1.23M Buy
42,745
+21,390
+100% +$613K ﹤0.01% 1757
2014
Q4 		$581K Sell
21,355
-13,099
-38% -$312K ﹤0.01% 2176
2014
Q3 		$734K Sell
34,454
-18,296
-35% -$419K ﹤0.01% 1967
2014
Q2 		$1.19M Buy
52,750
+2,801
+6% +$65.2K ﹤0.01% 1725
2014
Q1 		$1.26M Sell
49,949
-2,769
-5% -$69.9K ﹤0.01% 1869
2013
Q4 		$1.21M Buy
52,718
+4,163
+9% +$86.8K ﹤0.01% 1868
2013
Q3 		$924K Buy
48,555
+6,899
+17% +$123K ﹤0.01% 1953
2013
Q2 		$600K Buy
+41,656
New +$603K ﹤0.01% 2005

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Group's EBS Position: Q4 2016 in Review

BlackRock Group increased its Emergent Biosolutions (EBS) stake by 25% in Q4 2016, buying an estimated $513K and bringing the position to 85,199 shares worth $2.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1530.

BlackRock Group first reported a position in EBS in Q2 2013 and has held it in 15 quarters since. 208 funds tracked by Wall St. Rank hold EBS as of Q4 2016.

  • BlackRock Group held 85,199 shares of Emergent Biosolutions worth $2.8M as of Q4 2016.
  • BlackRock Group bought 17,107 Emergent Biosolutions shares in Q4 2016, an estimated $513K.
  • Emergent Biosolutions made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1530 holding.
  • BlackRock Group first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 15 quarters since.
  • 208 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.